- Find
- Manage
- Resources
Why Must Procardia Be Extended Release To Treat Hypertension?
Pronounced: (nye-FED-i-peen)
Interactions
See also the How to Use section.
Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of:
- phenytoin
- quinidin...
More information on "Why Must Procardia Be Extended Release To Treat Hypertension?"
From Our Experts
Extended-Release Hydrocodone on the Horizon
Last week Zogenix, Inc., a pharmaceutical company that develops products for treating central nervous system disorders and pain, announced... Read more »
Understanding Extended-Release Medications
Many of you have had questions about extended-release medications. Although many different types of medication come in extended-release... Read more »
New Extended-Release Hydromorphone Approved
This week the FDA approved Exalgo, the first extended-release form of the opioid pain reliever hydromorphone. Exalgo is for the... Read more »
A Free Diabetes Drug: Metformin or Glucophage, Immediate or Extended...
A supermarket chain in the Midwest United States, Meijer, has just announced that they will be giving away metformin at their pharmacies.... Read more »
From Our Sources
FDA Approves Generic Extended-Release Effexor
The U.S. Food and Drug Administration has approved the first generic version of Effexor XR (venlafaxine hydrochloride) to treat major depressive... Read more »
Understanding Extended-Release Medications
We're often asked questions about extended-release medications and how they are used. Following are the most frequently asked questions. Q: ... Read more »
New Extended-Release Painkiller Available
Exalgo, a new extended-release form of the narcotic hydromorphone, has been released by drugmaker Covidien, a company press release reports. The drug... Read more »
FDA Wants More Data on Extended Release Tapentadol
Officials with the U.S. Food and Drug Administration (FDA) have asked drugmaker Johnson & Johnson for more information on a new extended release... Read more »
Clinical trial: Extended-release Invega for teens with schizop...
This is a study to evaluate the long-term safety and tolerability of flexible doses of extended-release Invega in teens who have been diagnosed with... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
